companydata.dkcompanydata.dk

BIOCHEMFUSION HOLDING ApS: Financial statements 2023

CVR: 35398953

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

BIOCHEMFUSION HOLDING ApS (CVR 35398953) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 24,747 and a net result of DKK 12,286 compared with DKK 159,194 the year before. That is an increase of 20.1% compared with the year before. The profit margin was 49.6%. Equity in the 2023 report amounted to DKK 317,135. The solvency ratio was 99.4%.

Revenue
DKK 24,747
Gross Profit
DKK 15,751
Profit/Loss
DKK 12,286
Equity
DKK 317,135
Total Assets
DKK 319,193
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202325 t.16 t.12 t.317 t.0
202221 t.14 t.159 t.455 t.0
202145 t.39 t.178 t.446 t.0
2020-842450 t.567 t.0
2019-43 t.633 t.717 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

BIOCHEMFUSION HOLDING ApS: The 2022 annual report is outMay 24, 2023

BIOCHEMFUSION HOLDING ApS has published its annual report for 2022. Revenue came to DKK 20,606, and the net result was DKK 159,194.

About BIOCHEMFUSION HOLDING ApS

BIOCHEMFUSION HOLDING ApS is a Danish company of the type Anpartsselskab based in Ølsted, founded in 2013. The company is registered under the industry Finansielle holdingselskaber. The management consists of Jan Holst Jensen. The company is owned by JAN HOLST HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported revenue of DKK 28,888 and a net result of DKK 16,110 compared with DKK 93,935 the year before. Equity in the 2025 report amounted to DKK 226,586.

Source: annual report 2025, Danish Business Authority